Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 425

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 425
---
 with the SEC on May 28, 2024).                                                                                                                                                                                                                                                     
 Form of Warrant Agent Warrant (incorporated by reference to Exhibit 4.3 of the Company’s Report on Form 6-K, filed with the SEC on May 28, 2024).                                                                                                                                                                                                                                                |
|:-------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.21   | Form of Series J Warrant (incorporated by reference to Exhibit 4.1 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                                                                                                                                    |
| 4.22   | Form of Series K Warrant (incorporated by reference to Exhibit 4.2 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                                                                                                                                    |
| 4.23   | Form of July 2024 Placement Agent Warrant (incorporated by reference to Exhibit 4.3 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                                                                                                                   |
| 4.24   | Form of Pre-Funded Warrant  (incorporated by reference to Exhibit 4.4 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                                                                                                                                 |
| 5.1*   | Opinion of Brown Rudnick LLP.                                                                                                                                                                                                                                                                                                                                                                    |
| 10.1

#  | Biodexa PLC Enterprise Management Incentive and Unapproved Share Option Scheme (incorporated by reference to Exhibit 4.1 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the SEC on April 19, 2024).                                                                                                                                                |
| 10.2

#  | Form of Option Agreement (included in Exhibit 10.1).                                                                                                                                                                                                                                                                                                                                             |
| 10.3

#  | Consultancy Agreement, dated as of April 15, 2014, by and between Midatech Limited and Chesyl Pharma Limited (incorporated by reference to Exhibit 10.17 to the Company’s Registration Statement on Form F-4 (File No. 333-206305), originally filed with the SEC on August 11, 2015, as amended).                                                                                               |
| 10.4

#